Prevalence and Factors Associated With Pancreatic Enzyme Elevations Among Diabetic Children
NCT05392166 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2022-05-26
Summary
Acute pancreatitis was reported as a DKA associated complication. The true incidence and clinical significance of pancreatitis in children with DKA is unclear. And its diagnosis in children requires a high index of clinical suspicion . Severe hypertriglyceridemia is an uncommon T1D complication which is also due to insulin deficiency and which can trigger acute pancreatitis The triad of DKA, severe hypertriglyceridemia, and acute pancreatitis have been described in children, especially in those with new onset T1D, abdominal pain and vomiting occasionally prompt the measurement of pancreatic enzymes Previous studies indicate that pancreatic enzyme elevations, particularly increased serum lipase levels, are very common in children with DKA. The magnitude of lipase elevation appears to correlate with the degree of acidosis, whereas increased serum amylase level is nonspecific. The majority of patients with elevated enzymes had no significant abdominal symptoms or delay in their clinical recovery. In those with persistent abdominal symptoms after acidosis resolved, abdominal CT findings were normal. The results of previous pediatric studies were comparable to those from studies in adult patients with DKA. Amylase and/or lipase elevations have been reported in 24.7% to 79% of cases. However, the incidence of acute pancreatitis in DKA seems to be higher in adults compared with children and is reported to be more than 10% they also have found that pancreatic enzyme elevations occur much less commonly in the setting of new-onset diabetes without DKA. Consistent with this observation, pancreatic enzymes have been reported to be higher in patients with poorly controlled diabetes compared with those in good control. It was postulated to result from direct injury to the pancreas with enzyme leakage from the acini, secretion of amylase and lipase from non-pancreatic sources, and decreased renal clearance .Acute pancreatitis also is attributed to hypertriglyceridemia.
the diagnosis of Acute Pancreatitis requires 2 of the 3 criteria: (1) abdominal pain not due to other causes, (2) elevated serum lipase or amylase 3 times the upper limit of the normal reference range (ULN), and/or (3) imaging evidence of pancreatitis . But also, there are limitations associated with each criterion in children . Although abdominal pain is the most common presentation, up to one third of patients may not report abdominal pain and radiation of pain to the back occurs in5% .
Conditions
- Diabetic Children
Interventions
- DIAGNOSTIC_TEST
-
blood glucose, blood gases, serum electrolytes, HbA1c, complete blood count and serum creatinine. Serum calcium, serum amylase, serum lipase and serum triglycerides , abdominal ultrasound
blood samples will be collected at admission for assessment of blood glucose, blood gases, serum electrolytes, HbA1c, complete blood count and serum creatinine. Serum calcium, serum amylase, serum lipase and serum triglycerides will be assessed within the first 24 hours after hospital admission. For the control group, the blood samples will be collected during the pediatric diabetes clinic follow-up visits. Abdominal ultrasound will be done to all the study participants.
Sponsors & Collaborators
-
Sohag University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Day
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-05-13
- Primary Completion
- 2023-05-13
- Completion
- 2023-05-13
Countries
- Egypt
Study Locations
More Related Trials
-
Pancreatic Calcium Handling in Islet Beta Cells in Patients With Type 1 Diabetes Mellitus
NCT05298735 ·Status: COMPLETED
-
NEW ONSET ENDOCRINE DYSFUNCTION AFTER ACUTE PANCREATITIS
NCT04513197 ·Status: UNKNOWN
-
Diabetes RElated to Acute Pancreatitis and Its Mechanisms
NCT05197920 ·Status: RECRUITING
-
Intravenous Administration of Insulin and Plasma Exchange on Triglyceride Levels in Early Stage of Hypertriglyceridemia-induced Pancreatitis
NCT03342807 ·Status: UNKNOWN ·Phase: PHASE4
-
18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia
NCT01916148 ·Status: AVAILABLE
-
An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes
NCT02962492 ·Status: COMPLETED ·Phase: NA
-
β-cell Function in Type 1 Diabetes May Not Be As Low As Presumed
NCT02199470 ·Status: COMPLETED
-
Ketone Monitoring in T1D: Effect of SGLT2i During Usual Care and With Insulin Deficiency
NCT05541484 ·Status: COMPLETED ·Phase: PHASE4
-
Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes
NCT04079881 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Involvement of Steatosis-induced Glucagon Resistance in Hyperglucagonaemia
NCT02337660 ·Status: COMPLETED ·Phase: NA
-
Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)
NCT02914886 ·Status: COMPLETED ·Phase: PHASE4
-
The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-glucose Co-transporter-2 Inhibitors
NCT02792400 ·Status: COMPLETED ·Phase: NA
-
Relation of Glucose and Acute Pancreatitis
NCT01470885 ·Status: COMPLETED
-
Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options
NCT02365740 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM
NCT04965051 ·Status: UNKNOWN ·Phase: NA
-
Glucagon Responses During Oral- and iv Glucose in Patients With Type 1 Diabetes
NCT00704795 ·Status: UNKNOWN
-
SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia
NCT07053306 ·Status: RECRUITING ·Phase: PHASE1
-
Glucolipotoxicity and Type 2 Diabetes
NCT01375270 ·Status: COMPLETED ·Phase: NA
-
The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea
NCT03081676 ·Status: COMPLETED ·Phase: NA
-
Development and Evaluation of a Glucagon Sensitivity Test in Individuals With and Without Hepatic Steatosis
NCT04907721 ·Status: COMPLETED ·Phase: NA
-
SGLTi, Hepatic Glucose Production and Ketogenesis
NCT05960656 ·Status: RECRUITING ·Phase: PHASE1
-
Effect of Food Composition on Postprandial Insulin Secretion in Neonatal Diabetes
NCT02921906 ·Status: COMPLETED ·Phase: NA
-
Night Hyperglycemia and Fatty Liver in Type 1 Diabetes
NCT05933018 ·Status: UNKNOWN ·Phase: NA
-
Lypo-hypertrofia Characterization in Diabetes
NCT02278926 ·Status: COMPLETED
-
Mechanism Underlying Beta-cell Failure in Obese African Americans With History of Hyperglycemic Crises
NCT00753142 ·Status: COMPLETED ·Phase: NA